Svmuu News Bitget has officially launched GetClaw. By fully migrating the agent's operating environment to the cloud, users can start using it directly without the need for local deployment or technical background. Previously, using AI trading agents typically required users to possess certain technical skills or complete cumbersome local configurations. GetClaw completely eliminates this barrier through its cloud-based architecture, further lowering the entry barrier for AI trading tools.
In terms of functionality, GetClaw supports capabilities such as 24/7 market monitoring, memory of user position preferences, automatic execution of trading signals, and strategy backtesting, enabling the AI Agent to continuously optimize trading decisions based on market changes and user strategies. The current early access version has opened some core features, with trading functionalities to be launched with the official version. By deeply integrating AI automation capabilities with the trading execution system, Bitget further advances AI-driven trading tools from technical exploration to practical application scenarios.
Bitget Launches Plug-and-Play AI Agent GetClaw, Enabling Zero-Barrier Automated Execution
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
9
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
10
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
Markets Today
Recommended Reading








